カスタムアッセイ開発市場レポート：動向、予測、競合分析 (2031年まで)

世界のカスタムアッセイ開発市場の将来性は有望であり、医療、生物学、環境、学術市場に機会があります。世界のカスタムアッセイ開発市場は、2025年から2031年にかけてCAGR 7.7%の成長が見込まれています。この市場の主な促進要因は、個別化医療と標的治療に対する需要の増加、バイオマーカー探索と検証の進行です。

• Lucintel社は、種類別ではアッセイ開発が予測期間中に最も高い成長を遂げると予測しています。
• 用途別では、医療が最も高い成長を遂げる見込みです。
• 地域別では、北米が予測期間中に最も高い成長が見込まれます。

カスタムアッセイ開発市場の戦略的成長機会

カスタムアッセイ開発市場の幅広い用途は、主に技術的進歩と新興国市場の医療需要の進化により、いくつかの戦略的成長機会をもたらしています。

• ゲノミクス・プロテオミクス用アッセイ：様々な研究分野や臨床分野において、カスタムメイドのゲノム・アッセイやプロテオミクス・アッセイのニーズが高まっています。複雑な生物学的サンプルをプロファイリングできるアッセイの開発は、疾病メカニズムの理解を深め、個別化治療を促進します。
• 感染症の診断：感染症の負担が大きいため、迅速診断検査やカスタムアッセイシステムの開発が必要です。感染症診断に注力することは、多くの医療システムにおいて公衆衛生と個々の患者に利益をもたらします。
• 医薬品アウトカム：個別化医療の重視はコンパニオン診断薬の成長の可能性を後押ししています。このような特殊なアッセイは、患者が特定の治療にどのように反応するかを判定するのに役立ち、より良い治療計画と有効性を支援します。
• 環境アッセイ：カスタムアッセイ市場は、毒素や病原体を検出するために経皮アッセイや血液アッセイが使用される環境検査の動向とともに多様化しています。このようなアッセイを通じて汚染に対処することで、公衆衛生と保健法の遵守が促進されます。
• PoCアッセイ：広範なPoC（ポイント・オブ・ケア）ソリューションの必要性が高まっているため、PoC用カスタムアッセイの需要が高まっています。シンプルで費用対効果の高いポイントオブケア代替品を提供することで、タイムリーな検査へのアクセスにおける患者の不快感を軽減し、医療サービスの質を向上させることができます。

こうした成長機会は、カスタムアッセイサービス市場が大きく拡大することを示しています。これらの用途を活用することで、利害関係者はイノベーションを促進し、様々な分野の診断を強化することができます。

カスタムアッセイ開発市場の促進要因・課題

カスタムアッセイ開発市場は、技術面、経済面、規制面など、いくつかのダイナミックな要因の影響を受けており、利害関係者にとってはチャンスでもあり課題でもあります。

カスタムアッセイ開発市場を促進する要因は以下の通りです：

• 技術開発：技術開発：新製品の継続的な導入、特に工業的自動化と多重化を特徴とするアッセイ技術が市場成長に大きく貢献しています。これらの進歩はアッセイの有効性を高め、診断や研究利用の質を向上させる。
• 標的治療システムに対する需要の増加：患者中心の医療へのシフトは、特定のカスタムアッセイサービスに対する需要を支えています。この開発により、より良い、より的を絞った治療アプローチが可能になり、患者の転帰が改善され、市場の成長がもたらされます。
• 研究開発費の拡大：研究開発、特にバイオテクノロジーと医療への投資の増加がカスタムアッセイ市場を後押ししています。このような資金提供は創造性を育み、より優れた、より迅速なアッセイの創出を促進します。
• 支援政策：規制条項の拡大により、カスタムアッセイの承認プロセスはますます簡単になってきています。研究・診断の利害関係者はコンセプトの実施を奨励され、新しい診断薬の迅速な市場参入を促進しています。
• 国際的な健康イニシアティブ：世界の健康状態の改善への取り組みにより、正確でタイムリーな診断薬への需要が高まっています。カスタムアッセイは公衆衛生の向上に重要な役割を果たすため、市場規模が拡大しています。

カスタムアッセイ開発市場における課題は以下の通りです：

• 開発コストの高さ：カスタムアッセイの開発には、中小企業にとっては特にコストがかかります。このような経済的障壁は、新技術の利点を制限し、企業によっては市場参入を制限する可能性があります。
• 複雑な規制状況：アッセイ開発プロセスは、規制要件のために煩雑になりがちです。地域によっては厳しく複雑な規制があるため、製品の市場投入までの時間が長くなる可能性があります。
• 市場競争：カスタムアッセイサービス市場は非常に細分化されており、様々な企業が市場シェアを争っています。こうした競争はコストを押し上げ、競争力を維持するためには最新の調査が必要となります。

サマリー：カスタムアッセイ開発市場は、こうした市場促進要因・課題の組み合わせによって牽引され、形成されています。利害関係者は、この競合情勢の中で前進するために、機会を生かし、障害を最小化する戦略を考案することが極めて重要です。

目次

第1章 エグゼクティブサマリー

第2章 世界のカスタムアッセイ開発市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界のカスタムアッセイ開発市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界のカスタムアッセイ開発市場：種類別
  • アッセイ開発
  • アッセイ最適化
  • アッセイ変換
  • 新規分析対象物の開発
  • カスタムカップリング
  • カスタム活用
  • 試料試験
  • その他
• 世界のカスタムアッセイ開発市場：用途別
  • 医療
  • 生物学
  • 環境
  • 学術
  • その他

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界のカスタムアッセイ開発市場：地域別
• 北米のカスタムアッセイ開発市場
• 欧州のカスタムアッセイ開発市場
• アジア太平洋のカスタムアッセイ開発市場
• その他地域のカスタムアッセイ開発市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界のカスタムアッセイ開発市場の成長機会：種類別
  • 世界のカスタムアッセイ開発市場の成長機会：用途別
  • 世界のカスタムアッセイ開発市場の成長機会：地域別
• 世界のカスタムアッセイ開発市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のカスタムアッセイ開発市場の生産能力拡大
  • 世界のカスタムアッセイ開発市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• 2BScientific
• PerkinElmer
• Eurofins Discovery
• Thermos Fisher Scientific
• Creative Biolabs
• PlexBio
• Gyros Protein Technologies
• Mission Bio
• Sygnature Discovery
• AssayGate

The future of the global custom assay development market looks promising, with opportunities in the medicine, biology, environment, and academic markets. The global custom assay development market is expected to grow with a CAGR of 7.7% from 2025 to 2031. The major drivers for this market are increasing demand for personalized medicine and targeted therapies and ongoing advancement in biomarker discovery and validation.

• Lucintel forecasts that, within the type category, assay development is expected to witness the highest growth over the forecast period.
• Within the application category, medicine is expected to witness the highest growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Gain valuable insight for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Custom Assay Development Market

The custom assay development market is expanding while undergoing many changes due to the emergence of several trends. These trends reveal the market positioning and potential areas for development.

• Personalized Medicines Offer New Opportunities for Diagnostic Companies: The growth of personalized medicine is increasing the need for custom assays tailored to individual patient profiles. This situation attracts more complex diagnostics and therapies, which benefits patients and contributes to the overall progress of healthcare interventions.
• Addition of Artificial Intelligence and Automation: The use of artificial intelligence and simultaneous automation in the development of assays is increasing effectiveness and accuracy. These technologies optimize the design phase, minimize errors, and expedite the development of complex assays for new diagnostics.
• Growth of Multiplex Assays: Multiplex assays are transforming the market by enabling the simultaneous detection of several targets, thereby increasing the scope of diagnostics. This trend improves testing efficiency and conserves resources, which is advantageous in both clinical and research settings.
• Initiatives to Streamline Approvals for Custom Assays: More countries are adopting new regulations that simplify the approval process for custom assays, making standards more comprehensible for developers. This encouragement fosters new ideas and financial support for developing new assays, aiding market growth.
• Rising Significance of Point-of-Care Testing: The increasing demand for diagnostic procedures in doctors' offices or laboratories is driving advancements in custom assays. Innovations allow for timely diagnostics, enhancing the dynamics of change in a medically oriented healthcare system and promoting decentralization.

Such trends are being integrated into the custom assay development market to foster innovation, enhance efficiency, and, most importantly, provide personalized healthcare solutions.

Recent Developments in the Custom Assay Development Market

There have also been substantive developments in the custom assay development market stemming from technological advancements and strategic initiatives to improve testing accuracy and applicability.

• Advanced Multiplexing Technologies: Advanced multiplexing technologies enable the use of the same assay for the simultaneous measurement of various biomarkers. This marks a significant step towards improving research, clinical diagnostics, and decision-making, particularly in patient management.
• AI-Driven Assay Design: The assay design process is undergoing a revolution, largely due to the role of artificial intelligence. Understanding and simulating optimal assay conditions are part of AI algorithms that facilitate a more efficient test development process, allowing for quick dispensing of necessary test results in the medical field.
• Collaboration Initiatives: Partnerships and collaborations between biotech companies and research institutions are on the rise, helping to drive innovation in the study and development of assays. Such collaborations enhance resource sharing and aid in developing advanced assays that bring research closer to practical application.
• Growth in Emerging Countries: The development of custom assay services is rapidly expanding in less developed regions, especially in Asia. Local players are providing relevant and affordable products, increasing the market for diagnostics.
• Regulatory Improvements: New structured guidelines are opening doors for easier approval of custom assays. This development attracts relevant stakeholders to the field, promoting the creation of new strategies for assays.

These developments are changing the landscape of custom assay development by improving the quality and efficiency of testing solutions, ultimately leading to better healthcare systems.

Strategic Growth Opportunities for Custom Assay Development Market

A wide array of applications in the custom assay development market presents several strategic growth opportunities, primarily due to technological advancements and evolving healthcare demands.

• Assays for Genomics and Proteomics: There is a growing need for custom-made genomic and proteomic assays across various research and clinical areas. Creating assays that can profile complex biological samples will enhance the understanding of disease mechanisms and facilitate personalized therapies.
• Diagnosing Infectious Diseases: The high burden of infectious diseases necessitates the development of rapid diagnostic testing and custom-assayed systems. Focusing on infectious disease diagnostics benefits public health and individual patients in many healthcare systems.
• Pharmaceutical Outcomes: The emphasis on personalized medicine is driving growth potential for companion diagnostics. These specialized assays help determine how a patient will respond to specific therapies, aiding in better planning and effectiveness of treatments.
• Environmental Assays: The custom assay market is diversifying with the trend of environmental testing, where dermal and blood assays are used to detect toxins and pathogens. Addressing pollution through these assays promotes public health and compliance with health legislation.
• Point-of-Care Assays: The demand for point-of-care custom assays is rising due to the increasing need for extensive point-of-care solutions. Providing simple and cost-effective point-of-care alternatives will reduce patients' discomfort in accessing timely tests and improve healthcare service quality.

These growth opportunities indicate that the custom assay services market will expand significantly. By leveraging these applications, stakeholders can foster innovation and enhance diagnostics across various fields.

Custom Assay Development Market Driver and Challenges

The custom assay development market is influenced by several dynamic factors, including technological, economic, and regulatory aspects, which present both opportunities and challenges for stakeholders.

The factors driving the custom assay development market include:

• Technology Development: The continuous introduction of new products, especially assay technologies featuring industrial automation and multiplexing, has significantly contributed to market growth. These advancements enhance assay effectiveness and improve the quality of diagnostics and research utilization.
• Increase in Demand for Targeted Therapeutic Systems: The shift toward patient-centered care sustains the demand for specific custom assay services. This development enables better and more targeted treatment approaches, resulting in improved patient outcomes and market growth.
• Expansion of R&D Spending: Increased investment in research and development, particularly in biotechnology and healthcare, is boosting the custom assay market. This funding fosters creativity and the creation of better and faster assays.
• Supporting Policies: Widening regulatory provisions are making the approval process for custom assays increasingly straightforward. Stakeholders in research and diagnostics are encouraged to implement their concepts, facilitating quicker market entry for new diagnostics.
• Global Health Initiatives: Efforts to improve global health are increasing the demand for accurate and timely diagnostics. Custom assays play a crucial role in enhancing public health, thus expanding the market scope.

Challenges in the custom assay development market include:

• Unaffordable Development Costs: Developing custom assays can be particularly expensive for small and medium enterprises. These financial barriers may limit the advantages of new technologies and restrict market entry for some companies.
• Complex Regulatory Landscape: The process of developing assays can be cumbersome due to regulatory requirements. Stringent and convoluted rules in some regions can lengthen the time to market for products.
• Market Competition: The custom assay service market is highly fragmented, with various players competing for market share. This competition drives costs and necessitates up-to-date research to maintain a competitive edge.

In summary, the custom assay development market is driven and shaped by a combination of these drivers and challenges. It is crucial for stakeholders to devise strategies that capitalize on opportunities and minimize obstacles to advance in this competitive landscape.

List of Custom Assay Development Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, custom assay development companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the custom assay development companies profiled in this report include-

• 2BScientific
• PerkinElmer
• Eurofins Discovery
• Thermos Fisher Scientific
• Creative Biolabs
• PlexBio
• Gyros Protein Technologies
• Mission Bio
• Sygnature Discovery
• AssayGate

Custom Assay Development by Segment

The study includes a forecast for the global custom assay development market by type, application, and region.

Custom Assay Development Market by Type [Analysis by Value from 2019 to 2031]:

• Assay Development
• Assay Optimization
• Assay Conversion
• New Analyte Development
• Custom Coupling
• Custom Conjugation
• Sample Testing
• Others

Custom Assay Development Market by Application [Analysis by Value from 2019 to 2031]:

• Medicine
• Biology
• Environment
• Academic
• Others

Custom Assay Development Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Custom Assay Development Market

The market for developing specialized tests is constantly witnessing innovations, driven by technological advancements and an increasing need for customized diagnostic tools. The improvements in assay technology and a growing focus on personalized medicine are enabling the execution of better and more accurate tests in the healthcare and pharmaceutical industries. Here is a summary of recent developments in the United States, Chinese, German, Indian, and Japanese markets.

• United States: The custom assay market is experiencing significant expansion due to advances in multiplex assays and the rise of rapid testing methods. Firms are strategically positioning themselves in the personalized medicine segment, leading to a growing number of requests for assay development. Collaborative research between biotech companies and universities is enhancing research capabilities and accelerating development.
• China: There is increasing demand for custom assay development services in China, particularly in the fields of genomics and proteomics. Government investments in the health industry and biotechnology are fostering innovative development. Additionally, local companies are increasingly internationalizing the market by offering competitive rates and tailored solutions.
• Germany: Germany is a leading country in Europe, capturing a substantial market share in custom assay services. High-throughput screening technologies are becoming more prevalent in assay development processes. The incorporation of automation and artificial intelligence in biostatistics and biotechnologies is enabling researchers to enhance the sophistication of assay design for drug discovery and diagnosis.
• India: While a formal custom assay market is still emerging, India is currently experiencing a trend toward this sector due to rising demand for affordable diagnostic solutions. Advances in new technologies have empowered startups to produce cost-effective assays, particularly for infectious diseases. Collaborations with research organizations are further driving innovation in assay development.
• Japan: Japan is making significant strides in the technological advancement of custom assay activities. Increasing partnerships between industry and academic/community institutions are facilitating the introduction of more advanced and specific assays, essential for precision medicine and targeted therapy approaches.

Features of the Global Custom Assay Development Market

Market Size Estimates: Custom assay development market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Custom assay development market size by type, application, and region in terms of value ($B).

Regional Analysis: Custom assay development market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the custom assay development market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the custom assay development market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the custom assay development market by type (assay development, assay optimization, assay conversion, new analyte development, custom coupling, custom conjugation, sample testing, and others), application (medicine, biology, environment, academic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Custom Assay Development Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Custom Assay Development Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Custom Assay Development Market by Type
  • 3.3.1: Assay Development
  • 3.3.2: Assay Optimization
  • 3.3.3: Assay Conversion
  • 3.3.4: New Analyte Development
  • 3.3.5: Custom Coupling
  • 3.3.6: Custom Conjugation
  • 3.3.7: Sample Testing
  • 3.3.8: Others
• 3.4: Global Custom Assay Development Market by Application
  • 3.4.1: Medicine
  • 3.4.2: Biology
  • 3.4.3: Environment
  • 3.4.4: Academic
  • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Custom Assay Development Market by Region
• 4.2: North American Custom Assay Development Market
  • 4.2.1: North American Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
  • 4.2.2: North American Market by Application: Medicine, Biology, Environment, Academic, and Others
• 4.3: European Custom Assay Development Market
  • 4.3.1: European Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
  • 4.3.2: European Market by Application: Medicine, Biology, Environment, Academic, and Others
• 4.4: APAC Custom Assay Development Market
  • 4.4.1: APAC Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
  • 4.4.2: APAC Market by Application: Medicine, Biology, Environment, Academic, and Others
• 4.5: ROW Custom Assay Development Market
  • 4.5.1: ROW Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
  • 4.5.2: ROW Market by Application: Medicine, Biology, Environment, Academic, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Custom Assay Development Market by Type
  • 6.1.2: Growth Opportunities for the Global Custom Assay Development Market by Application
  • 6.1.3: Growth Opportunities for the Global Custom Assay Development Market by Region
• 6.2: Emerging Trends in the Global Custom Assay Development Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Custom Assay Development Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Custom Assay Development Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: 2BScientific
• 7.2: PerkinElmer
• 7.3: Eurofins Discovery
• 7.4: Thermos Fisher Scientific
• 7.5: Creative Biolabs
• 7.6: PlexBio
• 7.7: Gyros Protein Technologies
• 7.8: Mission Bio
• 7.9: Sygnature Discovery
• 7.10: AssayGate